2013-01-01
true
false
Private Limited Company
06086991
2013-12-31
06086991
2013-01-01
2013-12-31
06086991
2012-12-31
06086991
2012-01-01
2012-12-31
06086991
uk-bus:Director1
2013-01-01
2013-12-31
06086991
uk-bus:Director2
2013-01-01
2013-12-31
06086991
uk-gaap:Buildings
2013-01-01
2013-12-31
06086991
uk-gaap:PlantMachinery
2013-01-01
2013-12-31
06086991
uk-gaap:ToolsEquipment
2013-01-01
2013-12-31
06086991
uk-bus:OrdinaryShareClass1
2013-12-31
06086991
uk-bus:OrdinaryShareClass2
2013-12-31
06086991
uk-bus:OrdinaryShareClass3
2013-12-31
iso4217:GBP
| Clarity Biosolutions Limited |
For the year ended 31 December 2013
Unaudited Abbreviated Report and Financial Statements
England and Wales
Registered Number: 06086991
2
Clarity Biosolutions Limited
For the year ended 31 December 2013
1
Balance Sheet
2 to 3
Notes to the Abbreviated Financial Statements
3
| Abbreviated Balance Sheet |
Clarity Biosolutions Limited
2013
2012
2
13,608
17,376
13,608
17,376
6,200
-
9,440
41,345
18,859
7,288
60,204
22,928
| Creditors: amounts falling due within one year |
(4,400)
(15,940)
18,528
44,264
Net current assets
| Total assets less current liabilities |
57,872
35,904
| Creditors: amounts falling due after more than one |
| year |
(20,000)
(5,000)
52,872
Net assets
15,904
559
3
534
104,720
34,745
(52,407)
(19,375)
52,872
15,904
Shareholders funds
| For the year ended 31 December 2013 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. |
| Directors responsibilities: 1) The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476, |
| 2) The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts |
| These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime. |
| Date approved by the board: 26 September 2014 |
| Signed on behalf of the board of directors |
| C H Ballantine Dykes Director |
1 of 3
4
| Notes to the Abbreviated Financial Statements |
Clarity Biosolutions Limited
For the year ended 31 December 2013
| The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008). |
| Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. |
| Government grants received are credited to deferred income. Grants towards capital expenditure are released to the profit and loss account over the expected useful life of the assets. Grants received towards revenue expenditure are released to the profit and loss account as the related expenditure is incurred. |
| Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Land and Buildings
Plant and Machinery
Fixtures and Fittings
| Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. |
2 of 3
5
| Notes to the Abbreviated Financial Statements |
Clarity Biosolutions Limited
For the year ended 31 December 2013
34,810
34,810
17,434
3,768
Charge for year
21,202
13,608
17,376
| Allotted called up and fully paid |
2013
2012
| 25,800 Class A shares of £0.01 each |
258
258
| 25,800 Class B shares of £0.01 each |
258
258
| 4,297 Class C shares of £0.01 each |
18
43
559
534
| 2529 Class C £0.01 shares have been issued during the year at par for a cash consideration of £70000. |
3 of 3
